Neurohormonal therapies at baseline and follow-up and survival in wild-type transthyretin cardiac amyloidosis

ATTRwt-CA patients on beta-blockers or ACEi/ARB/ARNI at diagnosis did not have a shorter survival. Beta-blockers were discontinued less often than were ACEi/ARB/ARNI. There was no sign of better outcomes in patients discontinuing these therapies, or worse outcomes in those starting them.

Authors

Institutions

Publication Details

Journal
Journal of Cardiovascular Medicine
Published
2025-09-26
DOI
https://doi.org/10.2459/jcm.0000000000001800
Citations
1
Primary Topic
Amyloidosis: Diagnosis, Treatment, Outcomes
Type
article
Field-Weighted Citation Impact
0.81
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Neurohormonal therapies at baseline and follow-up and survival in wild-type transthyretin cardiac amyloidosis

Matteo Serenelli, Stefano Perlini, Federico Guerra, Andrea Foli et al.
1 citations
Journal of Cardiovascular Medicine
Amyloidosis: Diagnosis, Treatment, Outcomes
0.81
article

Neurohormonal therapies at baseline and follow-up and survival in wild-type transthyretin cardiac amyloidosis

Matteo Serenelli, Stefano Perlini, Federico Guerra, Andrea Foli, Alberto Cipriani, Simone Longhi, Francesca Marzo, Giuseppe Ciliberti, Beatrice Musumeci, Roberta Mussinelli, Maria Alessandra Schiavo, Laura De Michieli, Carlotta Mazzoni, Marco Basset, Giuseppe Vergaro, Pier Filippo Vianello, Giulia Elena Mandoli, Guerino Giuseppe Varrà, Giorgia Panichella, Federico Perfetto, Mattia Zampieri, Giuseppe Limongelli, Valeria Rella, Michele Emdin, Marco Merlo, Samuela Carigi, Irene Ruotolo, Emanuele Barbato, Lia Crotti, Enrico Monti, Elisa Gardini, Giacomo Tini, Laura Piera Obici, Elisa Merli, Marco Canepa, Elena Biagini, Italo Porto, Alessia Argirò, Francesco Cappelli, Giuseppe Palmiero, Michela Bartolotti, Paolo Milani, Giulia Saturi, Matteo Cameli, Giovanni Palladini, Gianfranco Sinagra, Margherita Zanoletti, Alberto Aimo, Ludovica De Fazio, Giulia Ricci Lucchi, F Fabris, Gioele Fabbri
article en
1 citations

Abstract

ATTRwt-CA patients on beta-blockers or ACEi/ARB/ARNI at diagnosis did not have a shorter survival. Beta-blockers were discontinued less often than were ACEi/ARB/ARNI. There was no sign of better outcomes in patients discontinuing these therapies, or worse outcomes in those starting them.

Journal of Cardiovascular MedicineVol. 26(11)
University of Siena (IT), Marche Polytechnic University (IT), University of Padua (IT), University of Trieste (IT), Scuola Superiore Sant'Anna (IT), University of Ferrara (IT), University of Pavia (IT), Azienda Unità Sanitaria Locale Della Romagna (IT), Azienda USL di Bologna (IT), Ospedale per gli Infermi (IT), University of Campania "Luigi Vanvitelli" (IT), Ospedale Infermi di Rimini (IT), IRCCS Istituto Auxologico Italiano (IT), Azienda-Unita' Sanitaria Locale Di Cesena (IT), Ospedale Monaldi (IT), ERN GUARD-Heart (NL), Ospedale Policlinico San Martino (IT), Policlinico San Matteo Fondazione (IT), Istituti di Ricovero e Cura a Carattere Scientifico (IT), Fondazione Toscana Gabriele Monasterio (IT), Azienda Sanitaria Universitaria Integrata di Trieste (IT), Ospedali Riuniti Umberto I (IT), University of Milano-Bicocca (IT), University of Genoa (IT), Sapienza University of Rome (IT), University of Bologna (IT)
Openalex Percentile: Top 21%
Amyloidosis: Diagnosis, Treatment, Outcomes
0.81
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.